How Lilly is using its Mounjaro millions to position as biotechs’ ‘partner of choice’

Eli Lilly’s explosion into the weight loss space is proving fruitful for shareholders, but it’s also providing fresh opportunities for biotechs looking for a Big Pharma partnership.

Lilly’s incubator arm, Gateway Labs, already operates two sites in South Francisco. The organization is set to expand to the east coast in August via a presence at the Lilly Institute for Genetic Medicine in Boston's Seaport district. That will be followed by another opening later this year in San Diego.